Jump to main content
Jump to site search

Issue 3, 2019
Previous Article Next Article

Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents

Author affiliations

Abstract

A new series of halogenated 4-thiazolidinone derivatives bearing the sulfonamide moiety was synthesized and characterized via FT-IR, 1H NMR, 13C NMR, HRMS and single crystal X-ray analysis. The newly synthesized target compounds were screened for their in vitro cytotoxicity on the HepG2 and MDA-MB-231 cell lines, and antimicrobial and antitubercular activity. The compounds showed promising anticancer activity towards the MDA-MB-231 cell line, and the trichloro derivatives with p-chloro substitution (6i) and p-hydroxy substitution (7e) exhibited excellent anticancer activity. Compounds 6b and 7c were observed to be moderate antimicrobial agents. The seven most potent anticancer agents were further studied for their antitubercular activity against an M. tuberculosis strain and it was found that compound 7e showed significant antitubercular activity. The potent candidates were also tested for hemolysis activity against human RBC cells and were found to be non-toxic. The mode of action for the observed anticancer activity was further supported by molecular docking studies of the potent compounds against the enzyme Aurora kinase (PDB ID: 4ZTR). Molecular dynamics (MD) simulations were further performed to study the stability of the ligand–protein complex.

Graphical abstract: Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 23 Jul 2018, accepted on 16 Nov 2018 and first published on 04 Dec 2018


Article type: Paper
DOI: 10.1039/C8NJ03671C
Citation: New J. Chem., 2019,43, 1597-1610
  •   Request permissions

    Synthesis, structural, biological and in silico studies of new 5-arylidene-4-thiazolidinone derivatives as possible anticancer, antimicrobial and antitubercular agents

    A. Sunil Kumar, J. Kudva, B. R. Bharath, K. Ananda, R. Sadashiva, S. Madan Kumar, B. C. Revanasiddappa, V. Kumar, P. D. Rekha and D. Naral, New J. Chem., 2019, 43, 1597
    DOI: 10.1039/C8NJ03671C

Search articles by author

Spotlight

Advertisements